TY  - JOUR
AU  - Palomares, Belen
AU  - Ruiz-Pino, Francisco
AU  - Garrido-Rodriguez, Martin
AU  - Eugenia Prados, M
AU  - Sánchez-Garrido, Miguel A
AU  - Velasco, Inmaculada
AU  - Vazquez, María J
AU  - Nadal, Xavier
AU  - Ferreiro-Vera, Carlos
AU  - Morrugares, Rosario
AU  - Appendino, Giovanni
AU  - Calzado, Marco A
AU  - Tena-Sempere, Manuel
AU  - Muñoz, Eduardo
PY  - 2019
DO  - 10.1016/j.bcp.2019.113693
UR  - http://hdl.handle.net/10668/14663
T2  - Biochemical pharmacology
AB  - Medicinal cannabis has remarkable therapeutic potential, but its clinical use is limited by the psychotropic activity of Δ9-tetrahydrocannabinol (Δ9-THC). However, the biological profile of the carboxylated, non-narcotic native precursor of Δ9-THC,...
LA  - en
PB  - Elsevier
KW  - Cannabis
KW  - Inflammation
KW  - Obesity
KW  - Pparγ
KW  - Δ9-THCA-A
KW  - 3T3-L1 Cells
KW  - Adipogenesis
KW  - Adiposity
KW  - Animals
KW  - Anti-Inflammatory Agents
KW  - Cells, Cultured
KW  - Diet, High-Fat
KW  - Dronabinol
KW  - Fatty Liver
KW  - HEK293 Cells
KW  - Humans
KW  - Male
KW  - Metabolic Diseases
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Obesity
KW  - PPAR gamma
KW  - Rosiglitazone
TI  - Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity.
TY  - research article
VL  - 171
ER  -